• Service
  • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • CER
  • About
Subscribe

Our Services

Strategy Consulting

  • Market Entry Strategy
  • Regulatory Strategy
  • Clinical Strategy
  • China Localization Strategy
  • Hainan Urgent Use Pathway
  • Innovation Pathway
  • Fast Track Pathway
  • Digital Health Consulting

Registration Affairs

  • Pre-market Registration
  • Modification Registration
  • Renewal Registration
  • Request for Classification
  • Legal Agent Representation
  • NMPA Expert Panel Meeting
  • NMPA Supplemental Notice

Quality Assurance

  • Postmarket Surveillance Compliance (IFU, Label, GSP)
  • Adverse Event Reporting
  • Recall Handling
  • Periodic Risk Evaluation Report
  • Annual QMS Self-Inspection Report
  • NMPA Inspections & Mock-Audit
  • QMS Establishment/Audit/Remediation
  • QA Gap Analysis
  • Factory Audit
  • Unique Device Identifier

Device Testing

  • China Local Type Testing
  • Device Modification Compliance Testing
  • Biocompatibility Testing
  • EMC Testing

Clinical Research Organization (CRO)

  • Clinical Trials/Research
  • Real-World Study
  • China CER & MDR CER
  • Clinical Evaluation Feasibility Assessment

Customized Training

  • China Regulatory Training
  • China QMS Training
  • China GCP Training
  • China Localization Training
  • Periodic Regulatory Updates Training

Other Services

  • Translation
  • Patent & Trademark
  • Distributor Evaluation & Audit
  • KOL Interview/Consultation
  • Investment
  • Global regulatory services
  • Service
  • Resources
    • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • About
  • CER
  • Subscribe
  • CN
  • US
  • Home
  • News
  • Regulations & Guidelines

News


  • Moments
  • Regulations & Guidelines
  • Fast Track Update
  • QMS/PMS
  • Other News
  • NMPA Monthly Newsletter
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021

Key Updates In New Version Of China GMP Compared With Old Version

2022-04-12

On March 22, 2022, NMPA published the updated version of China GMP (Good Manufacturing Practice) and GSP (Good…

China New GCP Effective Since May 1, 2022

2022-04-01

On March 31, 2022, NMPA officially released China new GCP (Medical Device Clinical Trial Quality Management Provisions, i.e.,…

Impacts From China Standard Update On Medical Device Registration

2022-04-01

During the whole process of medical device lifecycle, the standards will be updated periodically. For example, GB 9706.1-2020…

China NMPA Newsletter – February 2022

2022-04-01

Featured Articles NMPA Approval Summary Of Medical Devices In 2021 In 2021, NMPA approved 11,314 items of initial…

China Qualified Medical Device Clinical Sites Summary In 2021

2022-03-28

Since the promulgation and implementation of the Measures for the Administration of Medical Device Clinical Trial Institutions Conditions…

Interpretation Of Relevant Regulatory Documents And Response Strategies On China National Medical Device Quality Sampling And Inspection Work In 2022

2022-03-23

In recent years, with the national policy and the continuous adjustment and optimization of the industrial structure around…

NMPA Updated Guidelines On Software, Cybersecurity And AI

2022-03-17

On March 7, 2022, NMPA published the updated Registration Review Guidelines on Medical Device Cybersecurity (Revision 2022), Registration…

NMPA Approval Summary Of Medical Devices In 2021

2022-03-15

In 2021,NMPA approved 11,314 items of initial registration, renewal registration and change registration of medical devices, an increase…

NMPA Acceptance Summary Of Medical Device Registration Application In 2021

2022-03-02

NMPA Acceptance Summary of Medical Device Registration Application in 2021 In 2021, NMPA accepted 12,255 applications for initial…

China NMPA Newsletter – January 2022

2022-02-28

Featured Articles NMPA New Regulatory Framework Summary In 2021 In 2021, China NMPA established new regulatory framework for…

NMPA Strengthening The Supervision And Management Of Medical Device Registration

2022-02-27

In 2021, NMPA continues to strengthen the supervision and management of medical device registration. Class I filing surveillance…

NMPA Continues To Consolidate The Foundation Of Medical Device Registration Management

2022-02-27

In 2021, NMPA continues to consolidate the foundation of medical device registration management, ensuring the medical device developing…
« Prev...246...1011121314...18...Next »
Twitter Linkedin
United States
Email: info@bradyknowsmedical.com
Phone: +86 18600392020
China
Beijing Office: Room 1501-1502, East Ocean Centre, No. 24 A, Jianguomenwai Avenue, Chaoyang District, Beijing, China
Shanghai Office: Lingang New Zone, China (Shanghai) Pilot Free Trade Zone
Hainan Office: Boao Lecheng pilot zone of international medical tourism, Qionghai City, Hainan Province
Email: info@bradyknowsmedical.com
Phone: +86 18600392020 +86 10 65155991

©2025 Bradynuoen Beijing PharmTech Co Ltd All Rights Reserved.

京ICP备15042665号-7